The CytoBead assay-a novel kind of multiparametric autoantibody analysis in the diagnostics of systemic autoimmune diseases;Der CytoBead-Assay-Eine neue Möglichkeit der multiparametrischen Autoantikörperanalytik bei systemischen Autoimmunerkrankungen

LaboratoriumsMedizin

Volumn 38, Issue 6, 2014, Pages 309-317

  Sowa, Mandy ^a,b   Großmann, Kai ^b   Scholz, Juliane ^b   Röber, Nadja ^c   Rödiger, Stefan ^a   Schierack, Peter ^a   Conrad, Karsten ^c   Roggenbuck, Dirk ^a,b   Hiemann, Rico ^a  

^a Brandenburgische Technische Universität Cottbus Senftenberg   (United Kingdom)

^b GA Generic Assays GmbH   (United Kingdom)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoantibody; confirmation testing; indirect immunofluorescence; microparticle; multiparameter diagnostic; screening

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CYTOBEAD ASSAY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; HUMAN; IMMUNOFLUORESCENCE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 84916604624     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/labmed-2014-0041     Document Type: Article

References (48)

1. Conrad K, Roggenbuck D, Reinhold D, Sack U. Autoantibody diagnostics in clinical practice. Autoimmun Rev 2012;11: 207-11.
2. Conrad K, Sack U. Multiparameteranalytik in Diagnostik und Monitoring von Autoimmunerkrankungen: Stand und Perspek-tiven. J Lab Med 2011;35:375-82.
3. Chan EK, Fritzler MJ, Wiik A, Andrade LE, Reeves WH, Tincani A, et al. AutoAbSC.Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007;6:577-80.
4. Wiik A, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, et al. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 2006;15:391-6.
5. Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 2007;6:325-33.
6. Wiik AS. Diagnostische Strategien bei rheumatischen Autoim-munerkrankungen. Z Rheumatol 2007;66:219-4.
7. Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, et al. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003;120:312-8.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
9. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213.
10. Conrad K, Chan EK, Fritzler MJ, Humbel RL, Meroni PL, Shoenfeld Y. From prediction to prevention of autoimmune disease. 2011;7.
11. Sowa M, Grossmann K, Knutter I, Hiemann R, Rober N, Anderer U, et al. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. PLoS One 2014;9:e107743.
12. Roggenbuck D, Schierack P, Sack U, Lapin SV, Mazing AV, Toto-lian AA. Novel methods for autoantibody detection in laboratory diagnostics of autoimmune rheumatic diseases. Medical Immunology 2014;16:221-6.
13. Rodiger S, Schierack P, Bohm A, Nitschke J, Berger I, Frommel U, et al. A highly versatile microscope imaging technology platform for the multiplex real-time detection of biomolecules and autoimmune antibodies. Adv Biochem Eng Biotechnol 2013;133:35-74.
14. Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, Rödiger S, et al. New platform technology for comprehensive serolo-gical diagnostics of autoimmune diseases. Clin Dev Immunol 2012;2012:284740.
15. Rantapaa-Dahlqvist S. What happens before the onset of rheumatoid arthritis? Curr Opin Rheumatol 2009;21:272-8.
16. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13:R30.
17. Conrad K, Roggenbuck D, Reinhold D, Dorner T. Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 2009;9:431-5.
18. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
19. Grossmann K, Roggenbuck D, Schroder C, Conrad K, Schierack P, Sack U. Multiplex assessment of non-organ-specific autoanti-bodies with a novel microbead-based immunoassay. Cytometry A 2011;79:118-25.
20. Knutter I, Hiemann R, Brumma T, Buttner T, Grossmann K, Cusini M, et al. Automated interpretation of ANCA patterns-a new approach in the serology of ANCA-associated vasculitis. Arthritis Res Ther 2012;14:R271.
21. Mahler M, Fritzler MJ. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol 2012;2012:494356.
22. Fenger M, Wiik A, Hoier-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004;50:2141-7.
23. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
24. Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, et al. Autoantibody detection using indirect immunofluorescence on HEp-2 Cells. Ann N Y Acad Sci 2009;1173:166-73.
25. Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, et al. Autoantikörpernachweis mittels indirekter Immunfluoreszenz an Hep-2-Zellen. J Lab Med 2012;36:135-41.
26. Van Blerk M, Van Campenhout C, Bossuyt X, Duchateau J, Hum-bel R, Servais G, et al. Current practices in antinuclear antibody testing: results from the Belgian external quality assessment scheme. Clin Chem Lab Med 2009;47:102-8.
27. Op de Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801-8.
28. Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9:17-22.
29. Conrad K, Röber N, Rudorff S, Mahler M. DFS70-Autoantikörper-Biomarker zum Ausschluss ANA-assoziierter autoimmuner rheumatischer Erkrankungen. J Lab Med 2014;38:299-307.
30. Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic auto-antibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013;12:487-95.
31. Schulte-Pelkum J, Radice A, Norman GL, Hoyos ML, Lakos G, Buchner C, et al. Novel clinical and diagnostic aspects of anti-neutrophil cytoplasmic antibodies. J Immunol Res 2014;2014: 1-13.
32. Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med 2014;12:38.
33. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
34. Mierau R, Csernok E. Labordiagnostik bei Kollangenosen und Vaskulitiden. Akt Rheumatol 2014 2014;39:49-57.
35. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
36. Holle JU, Csernok E, Fredenhagen G, Backes M, Bremer JP, Gross WL. Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against protei-nase 3. Ann Rheum Dis 2010;69:468-9.
37. Sayegh J, Poli C, Chevailler A, Subra JF, Beloncle F, Deguigne PA, et al. Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis. Intern Emerg Med 2014. Oct 25. Epub 2014 Oct 25.
38. Hiemann R, Hilger N, Michel J, Nitschke J, Bohm A, Anderer U, et al. Automatic analysis of immunofluorescence patterns of HEp-2 cells. Ann N Y Acad Sci 2007;1109:358-71.
39. Roggenbuck D, Conrad K, Reinhold D. High sensitive detection of double-stranded DNA antibodies by a modified Crithidia luciliae immunofluorescence test may improve diagnosis of systemic lupus erythematosus. Clin Chim Acta 2010;411: 1837-8.
40. Conrad K, Ittenson A, Reinhold D, Fischer R, Roggenbuck D, Buttner T, et al. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunoflu-orescence test. Ann N Y Acad Sci 2009;1173:180-5.
41. George S, Paulick S, Knutter I, Rober N, Hiemann R, Roggenbuck D, et al. Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis. PLoS One 2014;9:e83924.
42. George S, Georgi M, Roggenbuck D, Conrad K, Kupper JH. A strategy for cell-based multiplex diagnostics of Myasthenia gravis and autoimmune encephalitis by modifying the subcellu-lar localization of cell membrane autoantigens. Clin Hemorheol Microcirc 2014;58:211-28.
43. Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, et al. Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems. Autoimmun Rev 2014;13:292-8.
44. Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, Radau B, et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010;12:R40.
45. Hiemann R, Roggenbuck D, Sack U, Anderer U, Conrad K. Die Hep-2-Zelle als Target für multiparametrische Autoantikörperanalytik-Automatisierung und Standardisierung. J Lab Med 2011;35:351-61.
46. Bonroy C, Verfaillie C, Smith V, Persijn L, De WE, De KF, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 2013;1-9.
47. Roggenbuck D, Hiemann R, Schierack P, Reinhold D, Conrad K. Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution. Clin Chem Lab Med 2014;52:e9-e11.
48. Roggenbuck D, Hiemann R, Bogdanos D, Reinhold D, Conrad K. Standardization of automated interpretation of immunofluores-cence tests. Clin Chim Acta 2013;421C:168-9.